EBM 2015 : Cardio Oncology - A New Focus In Cancer Care
Scientific Programme: Day 1: 27 February 2015 13th Floor, Homi Bhabha Block, TMH)
From 8 am
Registration
9.00-9.10
Introduction –Cancer and the Heart
Dr Aruna Alahari Dhir
Anthracycline Cardiotoxicity
9.10- 9.35
Mechanisms of anthracycline-induced cardiotoxicity
Dr Edward T Yeh
9.35 -9.40
TMH data (Early Cardiotoxicity)
Dr Anuprita Daddi
9.40 - 10.05
Risk stratification and monitoring for anthracycline
cardiotoxicity
Dr J B Durand
10.05 - 10.50
Role of cardiac biomarkers to assess cardiotoxicity in
cancer patients.
Dr Daniela Cardinale
Question & Answers
10.55– 11.10 : TEA BREAK
Cardiotoxicity Issues In Breast Cancer
11.10-11.30
Mechanisms of cardiotoxicity of HER2 targeted agents
Dr Edward T Yeh
11.30-11.45
Cardiovascular toxicity due to hormone therapy in
breast cancer
Dr Raghunadharao
11.45-12.10
Issues of chemotherapy induced cardiotoxicity in
patients with breast cancer.
Dr Susan Dent
12.10-12.55
Radiation and the heart
Dr Sarah Darby
Question & Answers
13.00 – 13.45 : LUNCH BREAK
13.45-14.25
Panel discussion (Case scenarios)
Imaging For Cardiotoxicity
Digumarti
14.25-14.55
Echocardiography in the evaluation of chemotherapy
patients.
Dr C K Ponde
14.55-15.10
Role of MUGA in detection of cardiotoxicity
Dr B A Krishna
15.10-15.30
MRI as a tool to predict chemotherapy-induced
cardiotoxicity
Question & Answers
Dr J B Durand
15.50-15.55
15.55-16.15
TKI cardiotoxicity – TMH data
Cardiotoxicity of TKIs
Dr Prakrithi
Dr Susan Dent
16.15-16.30
Guidelines for managing hypertension in patients
receiving VEGF inhibitors
Is there a cardiac concern with proteasome inhibitors
in haematologic malignancies ?
Dr Amit Joshi
5FU /capecitabine induced cardiotoxicity in GI
malignancies
Platinums and the heart
Rhythm disturbances with chemotherapy
Dr Sheela Sawant
15.35-15.50 : TEA BREAK
16.30-16.40
16.40-16.55
16.55-17.10
17.10-17.25
Question & Answers
Conference Dinner
Dr Manju Sengar
Dr Hemant Malhotra
Dr C K Ponde
EBM 2015: Cardio Oncology - A New Focus In Cancer Care
Scientific Programme : Day 2 : 28 February 2015 13th Floor, Homi Bhabha Block, TMH )
08.00-8.40 : Registration
8.40– 8.55
Dr C K Ponde
Chemotherapy in patients with pre existing
cardiac disease( stable IHD, valvular heart disease)
8.55- 9.00
Outcome of anthracycline induced
Cardiomyopathy (TMH Data)
Dr Sawant /Dr Daddi
9.00- 9.30
Management of symptomatic and Asymptomatic of
cancer therapy-induced Left ventricular dysfunction
Dr Daniela Cardinale
9.30-9.45
Acute coronary syndrome in patients with
chemotherapy induced thrombocytopenia
Dr J B Durand
9.45-10.00
Primary prevention of cardiotoxicity
Dr Susan Dent
10.00-10.15
Secondary prevention of cardiotoxicity
Dr Edward T Yeh
Question & Answers
10.20-10.35 : TEA BREAK
11.00 – 13.00 : HOSPITAL DAY Function
13.00-14.00 : LUNCH
Cardiotoxicity In Children, Adolescents And Young Adults
14.00-14.20
Cardiotoxicity and cardioprotective strategies in
children during chemotherapy .
Dr S S Prabhu
14.20-14.30
Childhood cancer cardiovascular toxicity –TMH data.
Dr Sawant / Dr Daddi
14.30-14.50
Long-term risk of various cardiovascular diseases after
different cancer treatments in adolescents and young
adults – monitoring guidelines
Dr Amita Trehan
14.50-15.30
Panel DiscussionSpecial issues in children
15.45-16.05
Interactions of chemotherapy and radiotherapy
Dr Sarah Darby
16.05-16.25
Can the childhood cancer survivor model be extended to
adults?
Dr Purvish Parikh
15.30-15.45 : TEA BREAK
Vote of Thanks

Oral Pathology

ACR Report

SUPREME COURT OF INDIA

Board of Studies for faculty of Agricultural Engineering and

Directory of Staff - Indian Institute of Forest Management